Top Biotechnology & Medical Research stocks in North America

Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.

Name
Market Cap
Price to Earnings
TTM
Dividend Yield
% TTM
us flag iconSGENSeagen$43.15bnn/an/a
us flag iconIQVIqvia Holdings$31.83bn25.59n/a
us flag iconINSMInsmed$30.85bnn/an/a
us flag iconBNTXBioNTech SE$23.26bnn/an/a
us flag iconTEMTempus AI (Pre-Reincorporation)$15.01bnn/an/a
us flag iconSMMTSummit Therapeutics$14.07bnn/an/a
us flag iconMEDPMedpace Holdings$13.78bn36.49n/a
us flag iconICLRIcon$13.61bn15.72n/a
us flag iconKRTXKaruna Therapeutics$12.58bnn/an/a
us flag iconASNDAscendis Pharma A/S$11.96bnn/an/a
us flag iconEXELExelixis$10.54bn17.63n/a
us flag iconEXASExact Sciences$10.21bnn/an/a
us flag iconIONSIonis Pharmaceuticals$10.07bnn/an/a
us flag iconQGENQiagen NV$9.82bn22.87n/a
us flag iconMDGLMadrigal Pharmaceuticals$9.63bnn/an/a
us flag iconRXDXPrometheus Biosciences$9.56bnn/an/a
us flag iconIMGNImmunoGen$8.72bnn/an/a
us flag iconRVMDRevolution Medicines$8.70bnn/an/a
us flag iconBPMCBlueprint Medicines$8.37bnn/an/a
us flag iconCERECerevel Therapeutics Holdings$8.19bnn/an/a